Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10246466 Diaryl macrocycles as modulators of protein kinases

Patent 10246466 was granted and assigned to TP Therapeutics on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

TP Therapeutics

Current Assignee

TP Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Dayong Zhai0

Jingrong Jean Cui0

Yishan Li0

Evan W. Rogers0

Date of Patent

April 2, 2019

Patent Application Number

15609962

Date Filed

May 31, 2017

Patent Citations Received

US Patent 12006306 Substituted pyridazines as TYK2 inhibitors

0

US Patent 10745416 Macrocyclic compounds for treating disease

US Patent 11008337 Chiral diaryl macrocycles as modulators of protein kinases

US Patent 11286264 Macrocyclic compounds and uses thereof

0

US Patent 11286265 Macrocyclic compounds for treating disease

0

US Patent 11291667 Combination therapy involving diaryl macrocyclic compounds

US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds

0

US Patent 11981684 Macrocyclic compounds and uses thereof

0

...

Patent Primary Examiner

Patent abstract

The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10246466 Diaryl macrocycles as modulators of protein kinases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool